Neogenomics Inc

NEO

Add to Watchlist

14.970USD

+0.380+2.60%

Close 07/01, 16:00（ET）Quotes delayed by 15 min

1.95BMarket Cap

LossP/E TTM

Neogenomics Inc

14.970

+0.380+2.60%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Neogenomics Inc's Company Valuation

Currency: USD Updated: 2026-07-01

Previous score

7.15

Change

The current valuation score of Neogenomics Inc is 7.15, ranking 58 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -19.39, which is -69.40% below the recent high of -5.93 and -54.65% above the recent low of -29.98.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/S

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.